Chicago health technology startup Tempus said it will collaborate with the University of Chicago to determine a smarter approach to improve treatment for breast cancer patients.Launched in 2015, Tempus will provide the University’s breast cancer experts with software and analytical tools that analyze clinical and molecular data that help physicians make real-time data-driven results.Specifically, Tempus will examine and study data from roughly 1,000 breast cancer patients. The information will lend a hand to doctors and researchers in finding patterns that can anticipate responses from patients and will guide the way to improved patient results.
Tempus, which has built an operating system to battle cancer, focuses on helping doctors with the medical care they give to their cancer patients by gathering, organizing and evaluating clinical and molecular data.Professor of medicine and human genetics and dean for global health at the University of Chicago, Dr. Olufunmilayo Olopade commented in a statement that there is a small amount of available data on the large number of patients who have struggled with the disease.She also stated the University is eager to partner with Tempus and looks forward to putting together a leading analytically molecular breast cancer data set.
Tempus has launched similar collaborations with the Mayo Clinic, the University of Michigan, the University of Pennsylvania and others to use data so patients will benefit from the treatment of others.As a Chicago serial entrepreneur and philanthropist, Lefkofsky co-founded Tempus, Groupon and other companies. He is also a co-founder of venture capital and consulting firm, Lightbank, which develops new companies in the Chicago area.His philanthropy activities include giving back to the community functioning as chairman of the Board of Trustees of Chicago’s Steppenwolf Theatre Company as well as a Trustee of Lurie Children’s Hospital of Chicago, The Art Institute of Chicago and more.He and his wife, Elizabeth, also set up the Lefkofsky Family Foundation, with a focus on developing the quality of life through medical research, human rights, education and cultural creativity.